SUPERNUS PHARMACEUTICALS, INC.
For the period ended Nov 2, 2026. Filed Nov 2, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 2, 2026 · Filed Nov 2, 2026
Use the contents to explore the available documents and sections.
SUPN$26.16-2.2%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · End note
End note
(1) As part of the closing process, Supernus Pharmaceuticals, Inc. will be delisted from Nasdaq. The combined company, Supernus, Inc., is expected to trade under the ticker symbol SUPN beginning on November 3, 2026. The combined company, Supernus, Inc., will trade under the ticker symbol INDV on November 2, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.